C31G, A NEW AGENT FOR ORAL USE .1. ANTIGLYCOLYTIC TESTS

被引：0
|
作者：
CORNER, AM [1 ]
DOLAN, MM [1 ]
MALAMUD, D [1 ]
YANKELL, SL [1 ]
机构：
[1] UNIV PENN,SCH DENT MED,PHILADELPHIA,PA 19104
来源：
JOURNAL OF DENTAL RESEARCH | 1986年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：274 / 274
页数：1
相关论文
共 50 条
  • [31] TOXICOLOGY OF GLISOXEPIDE, A NEW ORAL HYPOGLYCEMIC AGENT - RESULTS OF ANIMAL TESTS
    TETTENBORN, D
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1974, 24 (3A): : 409 - 418
  • [32] C31G in three concentrations: Safety study of once- and twice-daily dosing and post-coital study
    Mauck, CK
    XIV INTERNATIONAL AIDS CONFERENCE: PREVENTION SCIENCE, 2002, : 191 - 194
  • [33] A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II
    Mauck, CK
    Weiner, DH
    Creinin, MD
    Barnhart, KT
    Callahan, MM
    Bax, R
    CONTRACEPTION, 2004, 70 (03) : 233 - 240
  • [34] THE DESIGN, CONSTRUCTION AND USE OF STANDARDIZED TESTS .1.
    PIDGEON, DA
    EDUCATIONAL RESEARCH, 1961, 3 (02) : 89 - 99
  • [35] Sensitivity of HIV-1-susceptible immune cell targets to topical microbicides nonoxynol-9 (N-9), C31G, and sodium dodecyl sulfate (SDS).
    Miller, SR
    Krebs, FC
    Catalone, BJ
    Malamud, D
    Howett, MK
    Wigdahl, B
    ANTIVIRAL RESEARCH, 2000, 46 (01) : A50 - A50
  • [36] The new oral anticoagulants: clinical use and reversal agent development
    Costin, J.
    Ansell, J.
    Bakhru, S.
    Laulicht, B.
    Steiner, S.
    STATE OF THE ART PRESENTATIONS 33RD INTERNATIONAL CONGRESS OF THE INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION, IN CONJUNCTION WITH THE 33RD CONGRESS OF THE KSBT AND 2014 CONGRESS OF THE KOREAN HEMATOLOGY SOCIETIES, VOL 10, NO S1, 2015, 10 (S1): : 324 - 331
  • [37] PHARMACOKINETICS OF THE NEW ANTIHYPERTENSIVE AGENT NIPRADILOL IN RATS .1. METABOLISM AND DISPOSITION AFTER SINGLE ORAL-ADMINISTRATION OF [C-14] NIPRADILOL
    KABUTO, S
    KIMATA, H
    YONEMITSU, M
    KOIDE, T
    NAKAO, H
    SUZUKI, J
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1985, 35-2 (11): : 1674 - 1679
  • [38] A randomized controlled clinical trial on the effectiveness of three different mouthrinses (chlorhexidine with or without alcohol and C31G), adjunct to periodontal surgery, in early wound healing
    Anastasios M. Gkatzonis
    Spyridon I. Vassilopoulos
    Ioannis K. Karoussis
    Archontia Kaminari
    Phoebus N. Madianos
    Ioannis A. Vrotsos
    Clinical Oral Investigations, 2018, 22 : 2581 - 2591
  • [39] A randomized controlled clinical trial on the effectiveness of three different mouthrinses (chlorhexidine with or without alcohol and C31G), adjunct to periodontal surgery, in early wound healing
    Gkatzonis, Anastasios M.
    Vassilopoulos, Spyridon, I
    Karoussis, Ioannis K.
    Kaminari, Archontia
    Madianos, Phoebus N.
    Vrotsos, Loannis A.
    CLINICAL ORAL INVESTIGATIONS, 2018, 22 (07) : 2581 - 2591
  • [40] Survivin promoter-31G/C polymorphism in oral cancer cell lines
    De Maria, Salvatore
    Lo Muzio, Lorenzo
    Braca, Alessandra
    Rega, Paolo
    Cassano, Amalia
    Vinella, Angela
    Fumarulo, Ruggiero
    Serpico, Rosario
    Farina, Ernesto
    Metafora, Vittoria
    Pannone, Giuseppe
    Ravagnan, Gian Pietro
    Metafora, Salvatore
    Rubini, Corrado
    Carteni, Maria
    Mariggio, Maria Addolorata
    ONCOLOGY LETTERS, 2011, 2 (05) : 935 - 939
12345